Terns Pharmaceuticals halts its TERN-601 obesity program due to insufficient efficacy and safety concerns. Click here to read ...

We've been using one word to describe two opposite nervous system reactions. The confusion is real—and it's keeping you from ...

Jared Abbott, the director of the Center for Working-Class Politics, discusses what it would take for Democrats to better ...

We look at Tensor's ground-up approach to autonomy, its focus on safety and data privacy, and its readiness for real-world ...

Screenwriter Nora Garrett talks viral interviews, negative press and creating a button-pushing, era-defining film.

MeiTY released a draft amendment to the IT Rules to regulate synthetic information generated by AI companies, requiring ...

After a nimble rebrand, the thriving streaming service Dropout is doubling down on its focus on comedy, expanding into live ...

Interviewing the neuroscientist and primate behavior expert on a question that could radically change our understanding of ...

As guest of honour at Lyon's Lumière Film Festival this year, Sean Penn had a date with cinephiles for a masterclass ...

RAPT Therapeutics, Inc. ( NASDAQ: RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT Good morning, and welcome to RAPT's conference ...

For the New York Rangers' 100th season, however, they're taking it all the way back to the team's first season, 1926-1927, ...